Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Gentex Narrows FY2025 Sales Guidance from $2.440B-$2.610B to $2.500B-$2.600B vs $2.525B Est

Author: Benzinga Newsdesk | October 24, 2025 08:02am
Gentex (NASDAQ:GNTX) narrows FY2025 sales outlook from $2.440 billion-$2.610 billion to $2.500 billion-$2.600 billion vs $2.525 billion estimate.

Posted In: GNTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist